Expression and regulation of 12/15-lipoxygenases in human primary macrophages

Atherosclerosis

Volumn 225, Issue 1, 2012, Pages 121-127

  Wuest, Sophia J A ^a   Crucet, Margot ^b   Gemperle, Claudio ^a   Loretz, Christa ^a   Hersberger, Martin ^a,b  

^a UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

^b UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

12 15 Lipoxygenase; ALOX12; ALOX15; ALOX15B; Atherosclerosis; Human macrophages; Inflammation

Indexed keywords

ARACHIDONATE 12 LIPOXYGENASE; ARACHIDONATE 15 LIPOXYGENASE; ARACHIDONATE 15B LIPOXYGENASE; INTERLEUKIN 13; INTERLEUKIN 4; LIPOPOLYSACCHARIDE; MESSENGER RNA; UNCLASSIFIED DRUG;

ARTICLE; CELL DIFFERENTIATION; CELL HYPOXIA; CONTROLLED STUDY; HUMAN; HUMAN CELL; MACROPHAGE; MONOCYTE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; WESTERN BLOTTING;

ARACHIDONATE 12-LIPOXYGENASE; ARACHIDONATE 15-LIPOXYGENASE; ATHEROSCLEROSIS; CELL DIFFERENTIATION; CELL HYPOXIA; CELLS, CULTURED; HUMANS; INFLAMMATION; INTERLEUKIN-13; INTERLEUKIN-4; LIPOPOLYSACCHARIDES; MACROPHAGES; MONOCYTES; RNA, MESSENGER;

EID: 84867884637     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2012.07.022     Document Type: Article

References (34)

1. Wittwer J., Hersberger M. The two faces of the 15-lipoxygenase in atherosclerosis. Prostaglandins Leukot Essent Fatty Acids 2007, 77:67-77.
2. Shen J., Herderick E., Cornhill J.F., et al. Macrophage-mediated 15-lipoxygenase expression protects against atherosclerosis development. J Clin Invest 1996, 98:2201-2208.
3. Shen J., Kuhn H., Petho-Schramm A., Chan L. Transgenic rabbits with the integrated human 15-lipoxygenase gene driven by a lysozyme promoter: macrophage-specific expression and variable positional specificity of the transgenic enzyme. FASEB J 1995, 9:1623-1631.
4. Cyrus T., Witztum J.L., Rader D.J., et al. Disruption of the 12/15-lipoxygenase gene diminishes atherosclerosis in apo E-deficient mice. J Clin Invest 1999, 103:1597-1604.
5. Huo Y., Zhao L., Hyman M.C., et al. Critical role of macrophage 12/15-lipoxygenase for atherosclerosis in apolipoprotein E-deficient mice. Circulation 2004, 110:2024-2031.
6. Harats D., Shaish A., George J., et al. Overexpression of 15-lipoxygenase in vascular endothelium accelerates early atherosclerosis in LDL receptor-deficient mice. Arterioscler Thromb Vasc Biol 2000, 20:2100-2105.
7. Merched A.J., Ko K., Gotlinger K.H., Serhan C.N., Chan L. Atherosclerosis: evidence for impairment of resolution of vascular inflammation governed by specific lipid mediators. Faseb J 2008, 22:3595-3606.
8. Merched A.J., Serhan C.N., Chan L. Nutrigenetic disruption of inflammation-resolution homeostasis and atherogenesis. J Nutrigenet Nutrigenomics 2011, 4:12-24.
9. Wittwer J., Bayer M., Mosandl A., Muntwyler J., Hersberger M. The c.-292C>T promoter polymorphism increases reticulocyte-type 15-lipoxygenase-1 activity and could be atheroprotective. Clin Chem Lab Med 2007, 45:487-492.
10. Assimes T.L., Knowles J.W., Priest J.R., et al. A near null variant of 12/15-LOX encoded by a novel SNP in ALOX15 and the risk of coronary artery disease. Atherosclerosis 2008, 198:136-144.
11. Hersberger M., Muller M., Marti-Jaun J., et al. No association of two functional polymorphisms in human ALOX15 with myocardial infarction. Atherosclerosis 2009, 205:192-196.
12. Hersberger M. Potential role of the lipoxygenase derived lipid mediators in atherosclerosis: leukotrienes, lipoxins and resolvins. Clin Chem Lab Med 2010, 48:1063-1073.
13. Rydberg E.K., Krettek A., Ullstrom C., et al. Hypoxia increases LDL oxidation and expression of 15-lipoxygenase-2 in human macrophages. Arterioscler Thromb Vasc Biol 2004, 24:2040-2045.
14. Hulten L.M., Olson F.J., Aberg H., et al. 15-Lipoxygenase-2 is expressed in macrophages in human carotid plaques and regulated by hypoxia-inducible factor-1alpha. Eur J Clin Invest 2010, 40:11-17.
15. Gertow K., Nobili E., Folkersen L., et al. 12- and 15-lipoxygenases in human carotid atherosclerotic lesions: associations with cerebrovascular symptoms. Atherosclerosis 2011, 215:411-416.
16. Chaitidis P., O'Donnell V., Kuban R.J., Bermudez-Fajardo A., Ungethuem U., Kuhn H. Gene expression alterations of human peripheral blood monocytes induced by medium-term treatment with the TH2-cytokines interleukin-4 and -13. Cytokine 2005, 30:366-377.
17. Tang S., Bhatia B., Maldonado C.J., et al. Evidence that arachidonate 15-lipoxygenase 2 is a negative cell cycle regulator in normal prostate epithelial cells. J Biol Chem 2002, 277:16189-16201.
18. Martinez F.O., Sica A., Mantovani A., Locati M. Macrophage activation and polarization. Front Biosci 2008, 13:453-461.
19. Martinez F.O., Gordon S., Locati M., Mantovani A. Transcriptional profiling of the human monocyte-to-macrophage differentiation and polarization: new molecules and patterns of gene expression. J Immunol 2006, 177:7303-7311.
20. Chinetti-Gbaguidi G., Staels B. Macrophage polarization in metabolic disorders: functions and regulation. Curr Opin Lipidol 2011, 22:365-372.
21. Bouhlel M.A., Derudas B., Rigamonti E., et al. PPARgamma activation primes human monocytes into alternative M2 macrophages with anti-inflammatory properties. Cell Metab 2007, 6:137-143.
22. Chinetti-Gbaguidi G., Baron M., Bouhlel M.A., et al. Human atherosclerotic plaque alternative macrophages display low cholesterol handling but high phagocytosis because of distinct activities of the PPARgamma and LXRalpha pathways. Circ Research 2011, 108:985-995.
23. Murray P.J., Wynn T.A. Protective and pathogenic functions of macrophage subsets. Nat Rev Immunol 2011, 11:723-737.
24. Brash A.R., Boeglin W.E., Chang M.S. Discovery of a second 15S-lipoxygenase in humans. Proc Natl Acad Sci U S A 1997, 94:6148-6152.
25. Kuhn H., Barnett J., Grunberger D., et al. Overexpression, purification and characterization of human recombinant 15-lipoxygenase. Biochim Biophys Acta 1993, 1169:80-89.
26. Kilty I., Logan A., Vickers P.J. Differential characteristics of human 15-lipoxygenase isozymes and a novel splice variant of 15S-lipoxygenase. Eur J Biochem 1999, 266:83-93.
27. Hiltunen T., Luoma J., Nikkari T., Yla-Herttuala S. Induction of 15-lipoxygenase mRNA and protein in early atherosclerotic lesions. Circulation 1995, 92:3297-3303.
28. Yla-Herttuala S., Rosenfeld M.E., Parthasarathy S., et al. Colocalization of 15-lipoxygenase mRNA and protein with epitopes of oxidized low density lipoprotein in macrophage-rich areas of atherosclerotic lesions. Proc Natl Acad Sci U S A 1990, 87:6959-6963.
29. Kuhn H., Belkner J., Zaiss S., Fahrenklemper T., Wohlfeil S. Involvement of 15-lipoxygenase in early stages of atherogenesis. J Exp Med 1994, 179:1903-1911.
30. Yla-Herttuala S., Luoma J., Viita H., Hiltunen T., Sisto T., Nikkari T. Transfer of 15-lipoxygenase gene into rabbit iliac arteries results in the appearance of oxidation-specific lipid-protein adducts characteristic of oxidized low density lipoprotein. J Clin Invest 1995, 95:2692-2698.
31. Yla-Herttuala S., Rosenfeld M.E., Parthasarathy S., et al. Gene expression in macrophage-rich human atherosclerotic lesions. 15-lipoxygenase and acetyl low density lipoprotein receptor messenger RNA colocalize with oxidation specific lipid-protein adducts. J Clin Invest 1991, 87:1146-1152.
32. Kuhn H., Heydeck D., Hugou I., Gniwotta C. In vivo action of 15-lipoxygenase in early stages of human atherogenesis. J Clin Invest 1997, 99:888-893.
33. Spanbroek R., Grabner R., Lotzer K., et al. Expanding expression of the 5-lipoxygenase pathway within the arterial wall during human atherogenesis. Proc Natl Acad Sci U S A 2003, 100:1238-1243.
34. Wittwer J., Marti-Jaun J., Hersberger M. Functional polymorphism in ALOX15 results in increased allele-specific transcription in macrophages through binding of the transcription factor SPI1. Hum Mutat 2006, 27:78-87.